Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: Beam Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Royalty Pharma plc June 4, 202699.9%
-
Beam Therapeutics Inc. June 4, 202599.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 5, 2026 | Royalty Pharma plc | Grant or award | +4,545 | — | — |
| Aug 13, 2025 | Denali Therapeutics Inc. | Open-market sale | −806 | $14.64 | $11,800 |
| Aug 12, 2025 | Denali Therapeutics Inc. | Open-market sale | −2,937 | $13.58 | $39,884 |
| Aug 5, 2025 | Denali Therapeutics Inc. | Option exercise | +44,655 | $0.68 | $30,365 |
| Jul 31, 2025 | Royalty Pharma plc | Grant or award | +2,752 | — | — |
| Jul 31, 2025 | Royalty Pharma plc | Grant or award | +5,806 | — | — |
| Jan 7, 2025 | Denali Therapeutics Inc. | Open-market sale | −2,907 | $20.81 | $60,495 |
| Jan 6, 2025 | Denali Therapeutics Inc. | Open-market sale | −12,255 | $20.22 | $247,796 |
| Jan 3, 2025 | Denali Therapeutics Inc. | Grant or award | +54,180 | — | — |
| Nov 25, 2024 | Denali Therapeutics Inc. | Option exercise | +17,845 | $0.68 | $12,135 |
| Aug 21, 2024 | Denali Therapeutics Inc. | Open-market sale | −14,098 | $24.41 | $344,132 |
| Aug 21, 2024 | Denali Therapeutics Inc. | Open-market sale | −5,907 | $24.96 | $147,439 |
| Aug 20, 2024 | Denali Therapeutics Inc. | Open-market sale | −2,453 | $23.79 | $58,357 |
| Aug 13, 2024 | Denali Therapeutics Inc. | Open-market sale | −2,337 | $22.89 | $53,494 |
| Feb 14, 2024 | Denali Therapeutics Inc. | Open-market sale | −1,405 | $17.79 | $24,995 |
Questions about Carole Ho
What boards is Carole Ho on?
Carole Ho sits on the boards of Beam Therapeutics Inc. and Royalty Pharma plc.
How long has Carole Ho served on boards?
Our records show at least 5 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.